[Treatment of cancer of the thyroid].
D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion; D003036:Cobalt Isotopes; D006801:Humans; D007269:Injections, Intra-Arterial; D007456:Iodine Isotopes / Q000627:therapeutic use; D008197:Lymph Node Excision; D008727:Methotrexate / Q000627:therapeutic use; D037981:Neck Dissection; D010166:Palliative Care; D011867:Radioisotope Teletherapy; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013965:Thyroidectomy; D013972:Thyrotropin / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D003036:Cobalt Isotopes; D007456:Iodine Isotopes; D013972:Thyrotropin; D008727:Methotrexate
Tratamento do câncer da tireóide.